A detailed history of Empirical Finance, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Empirical Finance, LLC holds 88,158 shares of MRK stock, worth $8.96 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
88,158
Previous 86,174 2.3%
Holding current value
$8.96 Million
Previous $10.7 Million 6.16%
% of portfolio
0.59%
Previous 0.67%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$111.15 - $128.97 $220,521 - $255,876
1,984 Added 2.3%
88,158 $10 Million
Q2 2024

Jul 30, 2024

SELL
$123.8 - $132.96 $712,469 - $765,184
-5,755 Reduced 6.26%
86,174 $10.7 Million
Q1 2024

May 06, 2024

BUY
$113.24 - $131.95 $413,892 - $482,277
3,655 Added 4.14%
91,929 $12.1 Million
Q3 2023

Nov 02, 2023

BUY
$102.95 - $114.33 $916,563 - $1.02 Million
8,903 Added 11.22%
88,274 $9.09 Million
Q2 2023

Jul 27, 2023

BUY
$108.61 - $118.38 $976,403 - $1.06 Million
8,990 Added 12.77%
79,371 $9.16 Million
Q1 2023

Apr 05, 2023

BUY
$102.94 - $114.86 $394,260 - $439,913
3,830 Added 5.75%
70,381 $7.49 Million
Q4 2022

Jan 24, 2023

BUY
$87.44 - $112.11 $439,998 - $564,137
5,032 Added 8.18%
66,551 $7.38 Million
Q3 2022

Nov 04, 2022

BUY
$84.53 - $94.96 $844,961 - $949,220
9,996 Added 19.4%
61,519 $5.3 Million
Q2 2022

Aug 01, 2022

BUY
$83.49 - $94.64 $229,347 - $259,976
2,747 Added 5.63%
51,523 $4.7 Million
Q1 2022

Apr 21, 2022

BUY
$73.51 - $82.4 $728,263 - $816,336
9,907 Added 25.49%
48,776 $4 Million
Q4 2021

Feb 04, 2022

BUY
$72.28 - $90.54 $494,901 - $619,927
6,847 Added 21.38%
38,869 $2.98 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $127,518 - $140,238
1,779 Added 5.88%
32,022 $2.41 Million
Q2 2021

Aug 10, 2021

BUY
$70.31 - $77.77 $302,051 - $334,099
4,296 Added 16.56%
30,243 $2.35 Million
Q4 2020

Feb 02, 2021

BUY
$71.77 - $79.65 $320,022 - $355,159
4,459 Added 20.75%
25,947 $2.12 Million
Q3 2020

Oct 28, 2020

BUY
$73.18 - $82.95 $1.11 Million - $1.26 Million
15,231 Added 243.42%
21,488 $1.78 Million
Q3 2020

Oct 26, 2020

SELL
$73.18 - $82.95 $796,783 - $903,159
-10,888 Reduced 63.51%
6,257 $527,000
Q2 2020

Jul 20, 2020

BUY
$70.42 - $80.13 $348,508 - $396,563
4,949 Added 40.58%
17,145 $1.33 Million
Q2 2020

Jul 20, 2020

SELL
$70.42 - $80.13 $186,260 - $211,943
-2,645 Reduced 17.82%
12,196 $1.33 Million
Q1 2020

Apr 16, 2020

BUY
$63.36 - $87.82 $320,284 - $443,930
5,055 Added 51.66%
14,841 $1.14 Million
Q4 2019

Jan 27, 2020

BUY
$77.58 - $87.54 $273,779 - $308,928
3,529 Added 56.4%
9,786 $890,000
Q3 2019

Oct 30, 2019

BUY
$76.08 - $82.93 $8,520 - $9,288
112 Added 1.82%
6,257 $527,000
Q2 2019

Jul 09, 2019

SELL
$69.84 - $81.59 $8,660 - $10,117
-124 Reduced 1.98%
6,145 $515,000
Q1 2019

May 10, 2019

BUY
$69.58 - $79.36 $99,290 - $113,246
1,427 Added 29.47%
6,269 $521,000
Q4 2018

Jan 22, 2019

SELL
$65.24 - $75.71 $30,597 - $35,507
-469 Reduced 8.83%
4,842 $370,000
Q3 2018

Oct 18, 2018

BUY
$57.69 - $67.84 $33,921 - $39,889
588 Added 12.45%
5,311 $377,000
Q2 2018

Jul 09, 2018

SELL
$50.83 - $59.72 $78,583 - $92,327
-1,546 Reduced 24.66%
4,723 $287,000
Q1 2018

May 10, 2019

BUY
$50.96 - $59.23 $319,468 - $371,312
6,269 New
6,269 $521,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $257B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.